New stent aims to open blocked veins and heal leg ulcers
NCT ID NCT05409976
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 30 times
Summary
This trial is testing a new stent (a small mesh tube) to treat blockages in the large vein in the abdomen (inferior vena cava) and nearby leg veins. The study involves 136 adults with symptoms like leg ulcers, pain, or swelling. Doctors will place the stent to keep the vein open and check if it stays clear and safe over 12 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS THROMBOSES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Addenbrooke's Hospital
Cambridge, CB2 0QQ, United Kingdom
-
Alexianer Klinikum Hochsauerland GmbH
Arnsberg, 59759, Germany
-
Atrium Health-Sanger Heart and Vascular Institute
Charlotte, North Carolina, 28204, United States
-
Auckland City Hospital
Auckland, New Zealand
-
Flinders Medical Centre
Adelaide, South Australia, 5042, Australia
-
Hesperia Hospital
Modena, 41125, Italy
-
MedStar Washington Hospital Center
Washington D.C., District of Columbia, 20010, United States
-
Mount Sinai Medical Center
New York, New York, 10029, United States
-
Northwestern
Chicago, Illinois, 60611, United States
-
Ospedale San Raffaele
Milan, 20132, Italy
-
Sentara
Norfolk, Virginia, 23507, United States
-
St Thomas' Hospital
London, SE1 7EH, United Kingdom
-
Stanford University School of Medicine
Stanford, California, 94305, United States
-
University College Hospital GALWAY /Clinical Research Facility Galway
Galway, Connacht, H91 YR71, Ireland
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
-
Universitätsklinikum Aachen
Aachen, 52074, Germany
-
Weill Cornell Medical College
New York, New York, 10065, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
GORE VIAFORT vascular stent (a mesh tube placed inside a vein to keep it open)
What this could lead to
If it works, this stent could offer a safe and effective way to treat blocked veins in the abdomen and legs, relieving pain, swelling, and leg ulcers.
What could go wrong
This is an early-stage, single-arm study with no comparison group, so results may not apply to everyone. Risks include stent blockage, bleeding, or injury to the vein.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.